And whilst those things are nice they are developmental stage gloss - and not proven to make money until the receipts come flowing - which they are not yet.
When NUH first listed it also had a lot of development stage gloss surrounding its then product line which NUH appear to be somewhat moving away from and has not added many receipts to date.
You can only rely on development stage milestones for only so long - and when dilution becomes to extreme the market will refocus on production stage outputs (receipts and outflows.)
NUH may do exactly what it intends with the AUS and US hearing aid inclusion and obtain market traction - but it not a given. I am sure everyone thought previously NUH was going to sell millions of its original product line - but this did not occur.
Sometimes you need to ground yourselves out of the blue sky and review basic fundamentals.
Add to My Watchlist
What is My Watchlist?
